Galapagos NV (UK) (GB:0JXZ) has released an update.
Galapagos NV has announced the creation of new subscription right plans for its personnel across different subsidiaries, with 1,614,000 rights available, exercisable over eight years, and an exercise price of €26.90. These rights are part of a strategy to incentivize employees and if exercised will result in new shares listed on a regulated stock market. The company emphasizes its commitment to innovation in the biotechnology field, with a focus on developing medicines in oncology and immunology.
For further insights into GB:0JXZ stock, check out TipRanks’ Stock Analysis page.
